Patient Safety Authority Logo

Skip navigation links
HOME
PATIENT SAFETY AUTHORITYExpand PATIENT SAFETY AUTHORITY
PA-PSRS and PASSKEYExpand PA-PSRS and PASSKEY
PATIENT SAFETY ADVISORIESExpand PATIENT SAFETY ADVISORIES
PATIENTS AND CONSUMERSExpand PATIENTS AND CONSUMERS
NEWS AND INFORMATIONExpand NEWS AND INFORMATION
EDUCATIONAL TOOLSExpand EDUCATIONAL TOOLS
AUTHORITY EVENTSExpand AUTHORITY EVENTS







ADDRESS:

Patient Safety Authority
333 Market Street
Lobby Level
Harrisburg, PA 17120


Phone: 717-346-0469
Fax: 717-346-1090


 
Advisory Banner
Risk of Arrhythmia During Activation of Electrohydraulic Lithotripter
PA PSRS Patient Saf Advis 2005 Mar;2(1):8. 
 

PA-PSRS has received a report of a patient experiencing premature ventricular contractions (PVCs) during a procedure involving an intracorporeal electrohydraulic lithotripter (EHL). According to the hospital, a PVC occurred each time the EHL was activated.

The lithotripter electrode is inserted through the urethra using a cystoscope to remove stones from the bladder or nephroscope to remove stones from the kidney. With saline used for irrigation and the electrode placed near the bladder or kidney stone, the lithotripter is activated, generating a series of high-voltage sparks at the electrode tip. Sparks in the liquid medium generate a series of hydraulic shock waves, causing the stone to fracture.

Cardiac arrhythmias, though rare, can occur during EHL procedures. A review of FDA’s Manufacturer and User Facility Device Experience (MAUDE) database, from 1992 to the present, revealed three reports of patients’ experiencing abnormal cardiac rhythms during activation of the EHL generator. In two reports, patients experienced asystole. The rhythm returned to normal sinus rhythm when the EHL device was turned off. In the third report, the patient’s heart rate decreased, and the procedure was aborted with no reported injury to the patient.

Respective EHL device manufacturers’ responses in the MAUDE reports did not include definitive causes, but did suggest possible causes for the abnormalities in two of the three reports. One report in which the patient experienced asystole included a potential cause: that the patient was electrically grounded through the anesthesiologist, who may have been in physical contact with the patient during activation of the device. In the report concerning the patient’s decreased heart rate, the suggested cause was that the patient may have been electrically grounded through the patient electrodes and lead wires to the physiologic monitoring system used to monitor the patient’s vital signs during the procedure.

A review of MAUDE, also from 1992 to the present, revealed approximately 25 reports of electrical shocks experienced by the patient, anesthesiologist, surgeon, or a combination of individuals during EHL device activation.

In 1982, ECRI published a Hazard Report concerning anesthetists receiving electrical shocks during EHL bladder stone removal procedures.1 Based on the hospital reports, ECRI conducted experiments with several EHL device models. They determined that the magnitude of the electric current was sufficient to be perceived by a locally anesthetized patient or a clinician who becomes part of the current’s path to ground. The 1982 reports also described the possible occurrence of an electrical path to ground for stray lithotripter current from an intracardiac catheter or electrode. ECRI stated that the occurrence was rare, but potentially hazardous. With the use of an intracardiac or pacemaker catheter, the electrical pathway for current would be directed through cardiac tissue, possibly resulting in cardiac arrhythmias.

  • Methods that can help to mitigate the problem of electrical shocks or arrhythmias include:
  • Informing surgical staff of the possibility of shocks or cardiac arrhythmias occurring during EHL procedures.
  • Avoiding physical contact as much as possible between surgical staff and patients during activation of the EHL device.
  • Minimizing patient contact with grounded metal surfaces during procedures.
  • Avoiding EHL device use on patients who have externally connected intracardiac catheters.

Note

  1. ECRI. Electrohydraulic Lithotripters [Hazard Report]. Health Devices 1982 Dec;
    12(2):46-7.
 
 Browse by Topic
Navigation  



THE PENNSYLVANIA PATIENT SAFETY AUTHORITY AND ITS CONTRACTORS  
PSA LOGO The Pennsylvania Patient Safety Authority is an independent state agency created by Act 13 of 2002, the Medical Care Availability and Reduction of Error (“Mcare”) Act. Consistent with Act 13, ECRI Institute, as contractor for the Authority, is issuing this publication to advise medical facilities of immediate changes that can be instituted to reduce Serious Events and Incidents. For more information about the Pennsylvania Patient Safety Authority, see the Authority’s Web site at www.patientsafetyauthority.org .      
ECRI LOGO ECRI Institute, a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research in healthcare to uncover the best approaches to improving patient care. As pioneers in this science for more than 40 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. More than 5,000 healthcare organizations worldwide rely on ECRI Institute’s expertise in patient safety improvement, risk and quality management, and healthcare processes, devices, procedures and drug technology.      

ISMP Logo The Institute for Safe Medication Practices (ISMP) is an independent, nonprofit organization dedicated solely to medication error prevention and safe medication use. ISMP provides recommendations for the safe use of medications to the healthcare community including healthcare professionals, government agencies, accrediting organizations, and consumers. ISMP’s efforts are built on a nonpunitive approach and systems-based solutions.      
 
©2012 Pennsylvania Patient Safety Authority                                                Home      Who We Are      Contact Us     Subscribe to Advisories and Press Releases   Site Map     Privacy Statement